ITLN1 and cancer: Omentin concentrations in VAT were lowest in controls (≈20 ng mL−1), intermediate in weight-stable cancer (≈31 ng mL−1), and highest in cachectic patients (≈44 ng mL−1), indicating a disease- and weight-loss-dependent escalation.